➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Johnson and Johnson
AstraZeneca
Mallinckrodt
McKesson

Last Updated: March 8, 2021

DrugPatentWatch Database Preview

Filgrastim - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for filgrastim

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University College, LondonPhase 3
Canadian Cancer Trials GroupPhase 3
TakedaPhase 3

See all filgrastim clinical trials

Recent Litigation for filgrastim

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
2016-09-15
2012-09-25

See all filgrastim litigation

Company Disclosures: US Patents for filgrastim

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial Kirin- Amgen Inc. (Thousand Oaks, CA) 2006-03-07 RX company
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial Amgen Inc. (Thousand Oaks, CA) 2005-08-23 RX company
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial Amgen Inc. (Thousand Oaks, CA) 2013-12-03 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for filgrastim

These patents were identified by searching patent claims

Supplementary Protection Certificates for filgrastim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014 00004 Denmark   Start Trial PRODUCT NAME: LIPEGFILGRASTIM; REG. NO/DATE: EU/1/13/856 20130729
2014000005 Germany   Start Trial PRODUCT NAME: LIPEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/13/856/001-002 20130725
22-2014 Slovakia   Start Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928 20140522
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Merck
Colorcon
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.